Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 2226-2234, October 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanna, M. G.
Right arrow Articles by Snodgrass, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanna, M. G., Jr.
Right arrow Articles by Snodgrass, M. J.

Autogenous Immunity to Endogenous RNA Tumor Virus Antigens in Mice with a Low Natural Incidence of Lymphoma1

M. G. Hanna, Jr., R. W. Tennant, J. M. Yuhas, N. K. Clapp, B. L. Batzing and M. J. Snodgrass

Carcinogenesis Program, Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830

The immune reactivity to endogenous (wild-type) RNA tumor virus-related antigen(s) was evaluated in RF mice, a strain with a low natural incidence of lymphoma. The purposes were to determine whether maintained humoral immunity could be detected and to evaluate the response with respect to the immune-mediated pathogenesis of glomerulosclerosis and incidence of tumors of lymphatic origin. Measurements of detectable murine leukemia virus antigen in the thymus and spleen were correlated with the development of immune competence, glomerulosclerosis, and the incidence of lymphoid neoplasia. Also, the specificity of the antibody that lodged in the kidney was determined by elution and indirect immunofluorescence with Gross virus-infected cells. A marked decrease in detectable murine leukemia virus antigen in thymus and spleen was found to correlate with development of immunological competence of the spleen as assayed by de novo germinal-center formation, antigen localization, and immune elimination from serum, which in turn correlated with occurrence of glomerulosclerosis. The antibody in the kidney was determined to be specific for Gross virus antigen(s). The role of this autogenous immunity may be considered to be beneficial in the RF mouse, as data correlating natural lymphoid neoplasia with severity of immune-complex glomerulosclerosis indicates that an inverse relationship is established in aged animals.

1 Research supported jointly by the National Cancer Institute and the United States Atomic Energy Commission under contract with Union Carbide Corporation.

Received 4/21/72. Accepted 6/28/72.




This article has been cited by other articles:


Home page
ScienceHome page
R. C. Nowinski and S. L. Kaehler
Antibody to Leukemia Virus: Widespread Occurrence in Inbred Mice
Science, September 6, 1974; 185(4154): 869 - 871.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.